ARCA biopharma Inc (ABIO)
3.625
-0.02
(-0.68%)
USD |
NASDAQ |
Apr 24, 16:00
3.625
0.00 (0.00%)
After-Hours: 20:00
ARCA biopharma Free Cash Flow: -5.014M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.014M |
| September 30, 2023 | -5.452M |
| June 30, 2023 | -6.281M |
| March 31, 2023 | -8.209M |
| December 31, 2022 | -10.91M |
| September 30, 2022 | -14.37M |
| June 30, 2022 | -16.76M |
| March 31, 2022 | -17.87M |
| December 31, 2021 | -18.80M |
| September 30, 2021 | -16.86M |
| June 30, 2021 | -13.98M |
| March 31, 2021 | -11.29M |
| December 31, 2020 | -7.744M |
| September 30, 2020 | -5.896M |
| June 30, 2020 | -4.783M |
| March 31, 2020 | -4.928M |
| December 31, 2019 | -4.805M |
| September 30, 2019 | -4.988M |
| June 30, 2019 | -5.678M |
| March 31, 2019 | -6.742M |
| December 31, 2018 | -8.248M |
| September 30, 2018 | -11.10M |
| June 30, 2018 | -13.50M |
| March 31, 2018 | -16.20M |
| December 31, 2017 | -17.48M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.12M |
| June 30, 2017 | -16.89M |
| March 31, 2017 | -15.46M |
| December 31, 2016 | -15.00M |
| September 30, 2016 | -13.78M |
| June 30, 2016 | -12.44M |
| March 31, 2016 | -11.31M |
| December 31, 2015 | -10.54M |
| September 30, 2015 | -9.816M |
| June 30, 2015 | -9.489M |
| March 31, 2015 | -8.853M |
| December 31, 2014 | -9.425M |
| September 30, 2014 | -9.408M |
| June 30, 2014 | -9.018M |
| March 31, 2014 | -8.234M |
| December 31, 2013 | -5.32M |
| September 30, 2013 | -4.113M |
| June 30, 2013 | -3.201M |
| March 31, 2013 | -3.195M |
| December 31, 2012 | -4.078M |
| September 30, 2012 | -4.663M |
| June 30, 2012 | -5.564M |
| March 31, 2012 | -6.693M |
| December 31, 2011 | -6.978M |
| September 30, 2011 | -6.868M |
Free Cash Flow Range, Past 5 Years
-18.80M
Minimum
Dec 2021
-4.783M
Maximum
Jun 2020
-9.717M
Average
-7.744M
Median
Dec 2020
Free Cash Flow Benchmarks
| Shockwave Medical Inc | 165.46M |
| Asensus Surgical Inc | -64.19M |
| Glaukos Corp | -78.01M |
| Helius Medical Technologies Inc | -10.44M |
| Perspective Therapeutics Inc | -37.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.056M |
| Free Cash Flow Per Share (Quarterly) | -0.0732 |
| Free Cash Flow Yield | -9.59% |